Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 CPT code 53852

Transurethral destruction of prostate tissue by radiofrequency thermotherapy.

Modifiers may be applicable to indicate specific circumstances, such as increased procedural services (22), multiple procedures (51), or reduced services (52).

Medical necessity must be established by documenting the patient's symptoms, the failure of conservative treatment, or contraindications to alternative procedures. The documentation must support that the procedure is necessary for the patient's health and well-being.

The physician inserts a catheter and then needles through the catheter to the prostate, emitting radiofrequency waves to destroy excess tissue and control bleeding.

In simple words: This procedure uses heat from radio waves to shrink the prostate in men with an enlarged prostate.A small tube is inserted into the urinary opening, and then tiny needles are passed through the tube to the prostate.The needles emit radio waves, which heat and destroy excess prostate tissue.The heat helps to seal any bleeding.

The provider destroys prostatic tissue using radiofrequency ablation in male patients with benign prostatic hypertrophy.A specialized urethral catheter is inserted, dilating the urethra. Interstitial radiofrequency needles are then inserted through the catheter, piercing the prostatic urethra mucosa. Radiofrequency waves emitted from the needles heat and destroy the prostatic tissue while preserving the urethral mucosa. Electrocoagulation may be used to control bleeding. The catheter and probe are removed after the procedure.

Example 1: A 65-year-old male with benign prostatic hyperplasia (BPH) causing urinary obstruction undergoes transurethral destruction of prostate tissue by radiofrequency thermotherapy (53852)., A 70-year-old male experiences weak urine stream and frequent urination due to an enlarged prostate.He chooses radiofrequency thermotherapy over medication and is treated with 53852., A patient with BPH who is not a candidate for traditional surgery undergoes 53852 to reduce prostate size and alleviate lower urinary tract symptoms.

Documentation should include details of the procedure, size and location of treated tissue, pre- and post-procedure urinary symptoms, and any complications. Medical necessity should be justified by documenting failed medical management or contraindications to other treatments.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.